MMP2 promoter polymorphism (C-1306T) and risk of recurrence in patients with hepatocellular carcinoma after transplantation.

MMP2 promoter polymorphism (C-1306T) and risk of recurrence in patients with hepatocellular carcinoma after transplantation.

Item
http://www.wikidata.org/entity/Q53325341
Predictive value of CpG island methylator phenotype for tumor recurrence in hepatitis B virus-associated hepatocellular carcinoma following liver transplantation.Identification of histone deacetylase 3 as a biomarker for tumor recurrence following liver transplantation in HBV-associated hepatocellular carcinoma.Single-nucleotide polymorphisms of matrix metalloproteinases and their inhibitors in gastrointestinal cancer.Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation.Identification of cyclin B1 and Sec62 as biomarkers for recurrence in patients with HBV-related hepatocellular carcinoma after surgical resectionMethylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.Role of overexpression of MACC1 and/or FAK in predicting prognosis of hepatocellular carcinoma after liver transplantation.Prognostic indicators for tumor recurrence after liver transplantation in hepatocellular carcinoma and related molecular targeted therapy.O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation.The protective role of the -1306C>T functional polymorphism in matrix metalloproteinase-2 gene is associated with cervical cancer: implication of human papillomavirus infection.The MTHFR polymorphism affect the susceptibility of HCC and the prognosis of HCC liver transplantation.Combination of polymorphisms within the HDAC1 and HDAC3 gene predict tumor recurrence in hepatocellular carcinoma patients that have undergone transplant therapy.MicroRNA-424 expression predicts tumor recurrence in patients with hepatocellular carcinoma following liver transplantation.
P2860

MMP2 promoter polymorphism (C-1306T) and risk of recurrence in patients with hepatocellular carcinoma after transplantation.

Item
http://www.wikidata.org/entity/Q53325341
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
MMP2 promoter polymorphism (C- ...... rcinoma after transplantation.
@en
MMP2 promoter polymorphism
@nl
type
label
MMP2 promoter polymorphism (C- ...... rcinoma after transplantation.
@en
MMP2 promoter polymorphism
@nl
prefLabel
MMP2 promoter polymorphism (C- ...... rcinoma after transplantation.
@en
MMP2 promoter polymorphism
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
MMP2 promoter polymorphism (C- ...... rcinoma after transplantation.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1399-0004.2007.00955.X
P433
P478
P577
P698